Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000630846 | SCV000751815 | uncertain significance | Fanconi anemia | 2022-10-04 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 386 of the FANCG protein (p.Pro386Arg). This variant is present in population databases (rs141147618, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with FANCG-related conditions. ClinVar contains an entry for this variant (Variation ID: 134360). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt FANCG protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mayo Clinic Laboratories, |
RCV001507747 | SCV001713488 | uncertain significance | not provided | 2021-01-31 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001271366 | SCV002780335 | uncertain significance | Fanconi anemia complementation group G | 2021-11-18 | criteria provided, single submitter | clinical testing | |
Laboratory of Molecular Epidemiology of Birth Defects, |
RCV003153395 | SCV003843504 | benign | Ovarian cancer | 2022-01-01 | criteria provided, single submitter | clinical testing | |
ITMI | RCV000121034 | SCV000085202 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Natera, |
RCV001271366 | SCV001452477 | likely benign | Fanconi anemia complementation group G | 2019-10-28 | no assertion criteria provided | clinical testing |